Forecast: Pharmaceuticals in Dosage Market Size Value in Mexico

The pharmaceuticals in dosage market in Mexico stood at a value of 8.1283 billion USD in 2023. The data presents a declining trend from 2013 to 2023, with this value decreasing from 12.14 billion USD in 2013 to 8.1283 billion USD in 2023. Notable variations include a significant drop of 18.25% year-on-year in 2016 and more stable yet declining figures leading up to 2023, with the last year showing a 3.57% decline year-on-year. The compounded annual growth rate (CAGR) over the last five years indicates an average yearly decrease of -1.74%.

Forecasted data from 2024 to 2028 project continued decline, with an expected market value of 6.6673 billion USD by 2028. The forecast five-year CAGR stands at -3.16%, reflecting the anticipated downward trajectory.

Future trends to watch for include potential market shifts due to healthcare reforms, the impact of new pharmaceutical regulations, and evolving healthcare needs. Monitoring these factors will be key in understanding and potentially mitigating the decline. Moreover, developments in biotechnology and generic drugs could also play a significant role in shaping the market landscape.

- Consistent decline observed from 2013 to 2023.

- Significant year-on-year drops in some years, notably a 18.25% decrease in 2016.

- Latest figures show a 3.57% year-on-year decrease in 2023.

- Forecasted continued decline with a five-year CAGR of -3.16% towards 2028.